Navigation

Twitter
LinkedIn
SOCIALICON
TRON Translational Oncology Mainz | Connecting Competence TRON Translational Oncology Mainz | Connecting Competence
Twitter
LinkedIn
SOCIALICON
  • de
Home

main

  • About TRON
    • Overview
    • Translation
    • Background and History
    • Aims and Expertise
    • Faculty and Culture
    • Management
    • Supervisory Board
  • Research
    • Overview
    • Focus
    • Biomarkers
    • Immunotherapy
    • Preclinical Models
    • Publications
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
    • PhD Program
  • Facilities
    • Overview
    • Bioinformatics
    • Genomics
    • In Vivo Imaging
    • Serodiscovery
    • Validation
    • Vectors
  • Careers at TRON
  • News
  • Events
    • Overview
    • Seminars in Translational Oncology
    • Rudern gegen Krebs
    • Mainzer Firmenlauf
    • Mainzer Wissenschaftsallianz
Return to Content

EU Comission grants conditional marketing authorization for SARS-CoV-2 vaccine

By thomas on 22. December 2020 in spotlight-2017

For further information, please refer to the original press release.

U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use
Novel RNA-based therapy for treatment of autoimmune diseases

Gefördert vom Land Rheinland-Pfalz

278x24 (0x0)
0 B

Gefördert vom Bundesministerium für Bildung und Forschung

© 2020 TRON Mainz. All Rights Reserved

DATA PROTECTION | PRESS AND PR | CAREERS | TENDERS | CONTACT | GLOSSARY | IMPRINT | CONDITIONS